Watchdog setback for inhaled insulin
The manufacturer of a new form of insulin which allows patients to inhale rather than inject the drug has today hit out at the government's health watchdog.
The drug, Exubera, developed by Pfizer, is designed to offer adults with diabetes an alternative to daily insulin injections.
· Read The Full Diabetes Article From Norfolk Eastern Daily Press -->
·
Read All Diabetes News Stories -->